Frank Torti

Doer
DISC Type : sd

Vant Chair at Roivant Sciences

United States

Overview

Dr. Frank Torti is a prominent leader in the biopharmaceutical sector, serving as Vant Chair at Roivant Sciences and Executive Chairman at Immunovant. His career is highlighted by founding Telavant and leading it to a $7. 25B acquisition by Roche. He holds a unique combination of an MD from UNC and an MBA from Harvard.

He has a deep personal connection to medicine, as his father is a lifelong cancer doctor and a former Acting Commissioner at the United States Food and Drug Administration. Dr. Torti actively promotes his fathers work, underscoring a commitment to patient advocacy that extends beyond his corporate roles.

He has overseen companies that have advanced over forty medicines into clinical development and achieved positive phase three results in ten consecutive trials.

Personality Overview

Risk-Accepting

Deliberate Doer

Results Focused

Reading between the lines and seeing beyond your words comes naturally to them.  They exhibit a rare combination of being result-oriented but patient at the same time. They might take some time to make their mind up but once they do, they don't change it easily.

Topics They Care About

Biopharma Company Building
As Vant Chair at Roivant and founder of Telavant, his career is defined by creating, scaling, and leading biopharmaceutical companies to successful outcomes.
Healthcare Value Creation
He has been involved in generating over fifteen billion dollars in value, exemplified by the recent $7. 25B sale of Telavant to Roche.
Clinical Development
He is responsible for a portfolio of companies that have advanced over forty medicines into clinical trials, achieving numerous FDA approvals across multiple therapeutic areas.

Media Appearances

Frank has no verified media appearances

Work History

8-2018
Vant Chair at Roivant Sciences
8-2021
Executive Chairman at Immunovant
CEO and Chairman at Telavant (Acquired by Roche for $7.25B)
Partner at New Enterprise Associates

Education

MBA from Harvard Business School
MD from UNC School of Medicine

More Information

Social Presence :

Prographics :

Exp : 7 Location : United States Job Level : Junior Designation : Vant Chair at Roivant Sciences
URL has been copied!

Insights For Selling To Frank

During A Call Or A Meeting

DO's

  • You can spend time on BANT (or other qualification methodology) but keep it to the point
  • Let them know of potential risks but suggest mitigation methods alongside
  • During followups, use phone or text if needed, they should be fine

DONT's

  • Avoid putting conscious effort into relationship-building
  • Don't take their patience for granted, avoid long-winding sermons
  • Don't shy away from asking hard questions, but be extra polite

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Frank is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Frank

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Frank move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Frank take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Frank

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.